Send us Feedback

Amylin Pharmaceuticals (AMLN)
Analysis
Data
Financials
No Sales Breakout Data.
Balance Sheet    (USD)
Annual | Quarterly
QUARTER ENDING older 30-SEP
2008		 31-DEC
2008		 31-MAR
2009		 30-JUN
2009		 30-SEP
2009		 newer
Cash & Equivalents 197M 237M 180M 111M 111M
Short Term Investments 609M 580M 532M 533M 508M
Accounts Receivable 64.1M 66.0M 62.1M 76.4M 77.0M
Inventories 98.5M 116M 120M 110M 104M
Pre-paid Expenses 0 30.3M 0 0 0
Deferred Tax Assets 0 0 0 0 0
Other Current Assets 28.4M 7.02M 60.9M 64.8M 71.3M
Total Current Assets 997M 1.04B 954M 895M 872M
Property, Plant & Equipment 600M 637M 689M 715M 752M
Goodwill & Intangibles 0 0 0 0 0
Other Long-term Assets 35.9M 39.6M 34.3M 40.3M 39.2M
Total Long-Term Assets 636M 677M 723M 755M 791M
Total Assets 1.63B 1.71B 1.68B 1.65B 1.66B
Accounts Payable 39.8M 39.5M 104M 102M 94.4M
Accrued Expenses 0 0 0 0 0
Short Term Debt 23.4M 31.2M 31.2M 31.2M 31.2M
Other Current Liabilities 152M 122M 109M 101M 95.5M
Total Current Liabilities 279M 314M 280M 279M 277M
Long Term Debt 877M 869M 712M 710M 708M
Capital Lease Obligations 32.7M 31.7M 0 0 0
Deferred Income Tax 0 0 125M 143M 165M
Other Long-term Liabilities 0 148M 46.9M 48.1M 49.6M
Total Long-term Liabilities 909M 1.05B 884M 901M 923M
Minority Interest 0 0 0 0 0
Total Liabilities 1.19B 1.36B 1.16B 1.18B 1.20B
Preferred Stock 0 0 0 0 0
Common Par 138K 138K 141K 141K 142K
Additional Paid-In Capital 2.10B 2.11B 2.33B 2.34B 2.36B
Retained Earnings -1.65B -1.75B -1.81B -1.87B -1.90B
Treasury Stock 0 0 0 0 0
Other Equity -8.52M -11.0M -9.87M -4.18M -1.98M
Total Shareholder's Equity 444M 351M 514M 470M 463M
 
 
 
 
 
Data Sources:
Market and financial statement data provided by NASDAQ, BATS Exchange, SEC and Xignite Inc. Industry and operating metrics collected from company filings via EDGAR online. For more information on sources and calculations click here.
Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki